MedTrace Logo

A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)

NCT00798395 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2015-10-14

No results posted yet for this study

Summary

This trial is to investigate the effect on next-day driving performance and psychomotor performance in healthy volunteers.

Conditions

  • Sleep Initiation and Maintenance Disorders
  • Mental Disorders

Interventions

DRUG

Org 50081

1.5 mg on day 1-7

DRUG

Org 50081

4.5 mg on Day 1-7

DRUG

Placebo

Once daily on Day 1-7

DRUG

zopiclone

Single dose of 7.5 mg

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-09-30
Completion
2008-09-30

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00798395 on ClinicalTrials.gov